BioGaia AB (OTCPK:BGLAF)
$ 10.5 0 (0%) Market Cap: 1.01 Bil Enterprise Value: 901.37 Mil PE Ratio: 31.83 PB Ratio: 6.64 GF Score: 98/100

Q3 2021 Biogaia AB Interim Management Statement Call Transcript

Oct 21, 2021 / 07:30AM GMT
Release Date Price: $11
Operator

Ladies and gentlemen, welcome to the BioGaia audiocast with the teleconference Q3 2021. Today, I am pleased to present CEO, Isabelle Ducellier; and CFO, Alexander Kotsinas. (Operator Instructions) Speakers, please begin.

Isabelle Valerie Ghislaine Ducellier;publ;CEO;President
BioGaia AB

()-&

Yes, thank you so much. And thank you for attending BioGaia's Third Quarter Interim Management Statement. So we are actually pretty pleased with the third quarter with a sales of SEK 174 million that represents an increase of 32%. And if we would exclude the foreign exchange, an increase of 35% and an operating profit of SEK 67 million. I mean we are pleased with the third quarter.

We can see 3 external reasons for the good results. Firstly, an increased demand from consumer ahead of the winter season. I mean, people know that it's going to be cold, time for back to school, back to work, all the viruses are outside waiting for us and people are working on prevention and buying probiotics in advance.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot